Methylphenidate should be considered as a first choice for the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents, while amphetamines should be considered as a first choice in adults, according to a review published o
A UK-led international project has found that methylphenidate is the most effective and safest drug for children and adolescents with attention-deficit hyperactivity disorder (ADHD).